Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 263

1.

Vitamin D receptor FokI polymorphism and the risks of colorectal cancer, inflammatory bowel disease, and colorectal adenoma.

Cho YA, Lee J, Oh JH, Chang HJ, Sohn DK, Shin A, Kim J.

Sci Rep. 2018 Aug 27;8(1):12899. doi: 10.1038/s41598-018-31244-5.

2.

Mechanisms of action of vitamin D in colon cancer.

Ferrer-Mayorga G, Larriba MJ, Crespo P, Muñoz A.

J Steroid Biochem Mol Biol. 2018 Jul 4. pii: S0960-0760(18)30295-4. doi: 10.1016/j.jsbmb.2018.07.002. [Epub ahead of print] Review.

PMID:
29981368
3.

Vitamin D Regulation of the Uridine Phosphorylase 1 Gene and Uridine-Induced DNA Damage in Colon in African Americans and European Americans.

Bhasin N, Alleyne D, Gray OA, Kupfer SS.

Gastroenterology. 2018 Jun 30. pii: S0016-5085(18)34691-2. doi: 10.1053/j.gastro.2018.06.049. [Epub ahead of print]

PMID:
29964038
4.

Vitamin D and gastrointestinal cancer.

Mahendra A, Karishma, Choudhury BK, Sharma T, Bansal N, Bansal R, Gupta S.

J Lab Physicians. 2018 Jan-Mar;10(1):1-5. doi: 10.4103/JLP.JLP_49_17. Review.

5.

Vitamin D in esophageal cancer: Is there a role for chemoprevention?

Rouphael C, Kamal A, Sanaka MR, Thota PN.

World J Gastrointest Oncol. 2018 Jan 15;10(1):23-30. doi: 10.4251/wjgo.v10.i1.23. Review.

6.

Immunohystochemical Expression of Vitamin D Receptor in Development Stages of Colorectal Carcinoma.

Šutalo N, Tomić S, Bevanda M, Dragišić V, Marijanović I, Petričević J, Mikulić I.

Psychiatr Danub. 2017 Dec;29 Suppl 4(Suppl 4):855-858.

7.

Highlights from the 19th Workshop on Vitamin D in Boston, March 29-31, 2016.

Christakos S, White JH, Hewison M, Welsh J, Lips P, Bouillon R, Demay MB.

J Steroid Biochem Mol Biol. 2017 Oct;173:1-4. doi: 10.1016/j.jsbmb.2017.06.005. No abstract available.

PMID:
28895872
8.

Vitamin D receptor and calcium-sensing receptor polymorphisms and colorectal cancer survival in the Newfoundland population.

Zhu Y, Wang PP, Zhai G, Bapat B, Savas S, Woodrow JR, Sharma I, Li Y, Zhou X, Yang N, Campbell PT, Dicks E, Parfrey PS, Mclaughlin JR.

Br J Cancer. 2017 Sep 5;117(6):898-906. doi: 10.1038/bjc.2017.242. Epub 2017 Aug 1.

9.

Lactobacillus casei Zhang and vitamin K2 prevent intestinal tumorigenesis in mice via adiponectin-elevated different signaling pathways.

Zhang Y, Ma C, Zhao J, Xu H, Hou Q, Zhang H.

Oncotarget. 2017 Apr 11;8(15):24719-24727. doi: 10.18632/oncotarget.15791.

10.

Bile acids and colon cancer: Is FXR the solution of the conundrum?

Gadaleta RM, Garcia-Irigoyen O, Moschetta A.

Mol Aspects Med. 2017 Aug;56:66-74. doi: 10.1016/j.mam.2017.04.002. Epub 2017 Apr 21. Review.

PMID:
28400119
11.

Vitamin D Receptor-Dependent Signaling Protects Mice From Dextran Sulfate Sodium-Induced Colitis.

Wang F, Johnson RL, DeSmet ML, Snyder PW, Fairfax KC, Fleet JC.

Endocrinology. 2017 Jun 1;158(6):1951-1963. doi: 10.1210/en.2016-1913.

12.

H19 Overexpression Induces Resistance to 1,25(OH)2D3 by Targeting VDR Through miR-675-5p in Colon Cancer Cells.

Chen S, Bu D, Ma Y, Zhu J, Chen G, Sun L, Zuo S, Li T, Pan Y, Wang X, Liu Y, Wang P.

Neoplasia. 2017 Mar;19(3):226-236. doi: 10.1016/j.neo.2016.10.007. Epub 2017 Feb 8.

13.

Constitutively active RAS signaling reduces 1,25 dihydroxyvitamin D-mediated gene transcription in intestinal epithelial cells by reducing vitamin D receptor expression.

DeSmet ML, Fleet JC.

J Steroid Biochem Mol Biol. 2017 Oct;173:194-201. doi: 10.1016/j.jsbmb.2017.01.008. Epub 2017 Jan 16.

PMID:
28104492
14.

Vitamin D Reduces Colitis- and Inflammation-Associated Colorectal Cancer in Mice Independent of NOD2.

Elimrani I, Koenekoop J, Dionne S, Marcil V, Delvin E, Levy E, Seidman EG.

Nutr Cancer. 2017 Feb-Mar;69(2):276-288. doi: 10.1080/01635581.2017.1263346. Epub 2017 Jan 3.

PMID:
28045548
15.

Integrative genomic approaches to dissect clinically-significant relationships between the VDR cistrome and gene expression in primary colon cancer.

Long MD, Campbell MJ.

J Steroid Biochem Mol Biol. 2017 Oct;173:130-138. doi: 10.1016/j.jsbmb.2016.12.013. Epub 2016 Dec 24.

PMID:
28027912
16.

Control of Inflammatory Bowel Disease and Colorectal Cancer by Synthetic Vitamin D Receptor Ligands.

Takada I, Makishima M.

Curr Med Chem. 2017;24(9):868-875. doi: 10.2174/0929867323666161202145509. Review.

PMID:
27915991
17.

Vitamin D/VDR, Probiotics, and Gastrointestinal Diseases.

Shang M, Sun J.

Curr Med Chem. 2017;24(9):876-887. doi: 10.2174/0929867323666161202150008. Review.

18.

The endocrine vitamin D system in the gut.

Barbáchano A, Fernández-Barral A, Ferrer-Mayorga G, Costales-Carrera A, Larriba MJ, Muñoz A.

Mol Cell Endocrinol. 2017 Sep 15;453:79-87. doi: 10.1016/j.mce.2016.11.028. Epub 2016 Nov 29. Review.

PMID:
27913273
19.

Cross Talk between the Calcium-Sensing Receptor and the Vitamin D System in Prevention of Cancer.

Aggarwal A, Kállay E.

Front Physiol. 2016 Oct 18;7:451. eCollection 2016. Review.

20.

A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.

Bong YS, Assefnia S, Tuohy T, Neklason DW, Burt RW, Ahn J, Bueno De Mesquita PJ, Byers SW.

Oncotarget. 2016 Dec 6;7(49):80508-80520. doi: 10.18632/oncotarget.12768.

Supplemental Content

Loading ...
Support Center